当前位置：
X-MOL 学术
›
J. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
DKN-01 in Combination With Tislelizumab and Chemotherapy as First-Line Therapy in Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: DisTinGuish
Journal of Clinical Oncology ( IF 42.1 ) Pub Date : 2024 , DOI: 10.1200/jco.24.00410 Samuel J. Klempner, Mohamad Bassam Sonbol, Zev A. Wainberg, Hope Elizabeth Uronis, Vi K. Chiu, Aaron James Scott, Syma Iqbal, Mohamedtaki Abdulaziz Tejani, Vincent Chung, Melissa C. Stilian, Mathis Thoma, Ying Zhang, Michael H. Kagey, Jason Baum, Cynthia A. Sirard, Rachel A. Altura, Jaffer A. Ajani
Journal of Clinical Oncology ( IF 42.1 ) Pub Date : 2024 , DOI: 10.1200/jco.24.00410 Samuel J. Klempner, Mohamad Bassam Sonbol, Zev A. Wainberg, Hope Elizabeth Uronis, Vi K. Chiu, Aaron James Scott, Syma Iqbal, Mohamedtaki Abdulaziz Tejani, Vincent Chung, Melissa C. Stilian, Mathis Thoma, Ying Zhang, Michael H. Kagey, Jason Baum, Cynthia A. Sirard, Rachel A. Altura, Jaffer A. Ajani
Journal of Clinical Oncology, Ahead of Print.
中文翻译：
DKN-01 联合替雷利珠单抗和化疗作为晚期胃癌或胃食管结合部腺癌的一线治疗：DisTinGuish
临床肿瘤学杂志，提前印刷。
更新日期：2024-10-23
中文翻译：
DKN-01 联合替雷利珠单抗和化疗作为晚期胃癌或胃食管结合部腺癌的一线治疗：DisTinGuish
临床肿瘤学杂志，提前印刷。
京公网安备 11010802027423号